The leukemia controversy in myeloproliferative disorders: Is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?

被引:49
作者
Barbui, T [1 ]
机构
[1] Osped Riuniti Bergamo, Dept Hematol, I-24128 Bergamo, Italy
关键词
D O I
10.1053/j.seminhematol.2004.02.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:15 / 17
页数:3
相关论文
共 10 条
[1]  
BERK PD, 1986, SEMIN HEMATOL, V23, P132
[2]   Myelofibrosis with myeloid metaplasia following essential thrombocythaemia:: actuarial probability, presenting characteristics and evolution in a series of 195 patients [J].
Cervantes, F ;
Alvarez-Larrán, A ;
Talarn, C ;
Gómez, M ;
Montserrat, E .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (03) :786-790
[3]   Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial [J].
Finazzi, G ;
Ruggeri, M ;
Rodeghiero, F ;
Barbui, T .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) :577-583
[4]  
Fruchtman SM, 1997, SEMIN HEMATOL, V34, P17
[5]  
Fruchtman SM, 2002, BLOOD, V100, p70A
[6]   Interferon α in the treatment of polycythemia vera [J].
Lengfelder, E ;
Berger, U ;
Hehlmann, R .
ANNALS OF HEMATOLOGY, 2000, 79 (03) :103-109
[7]   Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years [J].
Najean, Y ;
Rain, JD .
BLOOD, 1997, 90 (09) :3370-3377
[8]  
Ruggeri M, 1998, BRIT J HAEMATOL, V103, P772
[9]   INTERFERON-ALPHA-2B - A NEW TREATMENT FOR POLYCYTHEMIA-VERA [J].
SILVER, RT .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (11) :1091-1092
[10]   Long-term use of anagrelide in young patients with essential thrombocythemia [J].
Storen, EC ;
Tefferi, A .
BLOOD, 2001, 97 (04) :863-866